Skip to main content

Exicure, Inc. (XCUR)

NASDAQ: XCUR · IEX Real-Time Price · USD
0.425
-0.031 (-6.72%)
At close: Dec 3, 2021 4:00 PM
0.440
0.015 (3.603%)
After-hours:Dec 3, 2021 7:21 PM EST
Market Cap37.42M
Revenue (ttm)-2.46M
Net Income (ttm)-62.96M
Shares Out88.12M
EPS (ttm)-0.72
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume307,708
Open0.451
Previous Close0.455
Day's Range0.422 - 0.480
52-Week Range0.422 - 2.830
Beta1.28
AnalystsStrong Buy
Price Target5.56 (+1,209.2%)
Earnings DateNov 18, 2021

About XCUR

Exicure, Inc., a clinical-stage biotechnology company, develops therapeutics for neurology, immuno-oncology, inflammatory diseases, and genetic disorders based on its proprietary spherical nucleic acid (SNA) technology. Its drug candidate includes cavrotolimod (AST-008) that is in a Phase 1b/2 clinical trials in patients with advanced solid tumors. The company is also developing XCUR-FXN, an SNA?based therapeutic candidate that is in preclinical trials for the treatment of Friedreich's ataxia; XCUR17, an SNA that targets the messenger RNA (mRNA...

IndustryBiotechnology
Founded2011
CEODavid Giljohann
Employees77
Stock ExchangeNASDAQ
Ticker SymbolXCUR
Full Company Profile

Financial Performance

In 2020, Exicure's revenue was $16.61 million, an increase of 1,181.87% compared to the previous year's $1.30 million. Losses were -$24.67 million, -6.22% less than in 2019.

Financial Statements

Analyst Forecast

According to 5 analysts, the average rating for Exicure stock is "Strong Buy." The 12-month stock price forecast is 5.56, which is an increase of 1,209.16% from the latest price.

Price Target
$5.56
(1,209.16% upside)
Analyst Consensus: Strong Buy

News

INVESTIGATION NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages I...

Los Angeles, California--(Newsfile Corp. - December 3, 2021) -  The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ex...

15 hours ago - Newsfile Corp

Exicure Shareholder Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

2 days ago - Newsfile Corp

Exicure Investor Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

3 days ago - Newsfile Corp

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages In...

Los Angeles, California--(Newsfile Corp. - November 28, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Ex...

5 days ago - Newsfile Corp

Exicure Update

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

1 week ago - Newsfile Corp

Exicure Shareholder Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

1 week ago - Newsfile Corp

EXICURE ALERT: Bragar Eagel & Squire, P.C. is Investigating Exicure, Inc. on Behalf of Exicure Stockholders and Encou...

NEW YORK--(BUSINESS WIRE)-- #Exicure--Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potential claims against Exicure, Inc. (“Exicure” or the “Company...

1 week ago - Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Continues Its Investigation of Exicure, Inc. (XCUR)...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, continues its investigation on behalf of Exicure, Inc. (“Exicure” or the “Company”) (NA...

2 weeks ago - Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Continues Its Investigation of Exicure, Inc. (XCUR) on Behalf of Inves...

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith continues its investigation on behalf of Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) investors concerning the Company's possi...

2 weeks ago - Business Wire

Exicure, Inc. (XCUR) Reports Q3 Loss, Lags Revenue Estimates

Exicure, Inc. (XCUR) delivered earnings and revenue surprises of -68.75% and 559.63%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

2 weeks ago - Zacks Investment Research

Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc. Reports Third Quarter 2021 Financial Results and Corporate Progress

2 weeks ago - Business Wire

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages...

LOS ANGELES--(BUSINESS WIRE)---- $XCUR #XCUR--INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc.

2 weeks ago - Business Wire

INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc. and Encourages In...

LOS ANGELES--(BUSINESS WIRE)---- $XCUR #XCUR--INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Exicure, Inc.

2 weeks ago - Business Wire

EQUITY ALERT: Rosen Law Firm Encourages Exicure, Inc. Investors with Losses in Excess of $100K to Inquire About Class...

NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Exicure, Inc. (NASDAQ: XCUR) res...

2 weeks ago - Business Wire

Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Exicure, Inc. (XCUR) on ...

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of Exicure, Inc. (“Exi...

2 weeks ago - Business Wire

Exicure Investor Alert

Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Exicure To Contact Him Directly To Discuss Their OptionsNew York, New York--(Newsfile Corp...

2 weeks ago - Newsfile Corp

The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors

LOS ANGELES--(BUSINESS WIRE)---- $XCUR #investors--The Law Offices of Frank R. Cruz Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors

2 weeks ago - Business Wire

INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Exicure, Inc. (XCUR) on Behalf of Investors

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of Exicure, Inc. (“Exicure” or the “Company”) (NASDAQ: XCUR) investors concerning the Company's possib...

2 weeks ago - Business Wire

Why Are Exicure Shares Trading At All Time Low?

Exicure Inc (NASDAQ: XCUR) has filed a Form 12b-25 with the U.S. SEC in connection with its Form 10-Q for the period ended September 30, 2021. On November 9, 2021, the Audit Committee of the Company's B...

2 weeks ago - Benzinga

Exicure Files Form 12b-25

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure, Inc.® (NASDAQ: XCUR) today announced that it has filed a Form 12b-25 with the U.S. Securities and Exchange Commission (the “SEC”) in connection with...

2 weeks ago - Business Wire

Earnings Preview: Exicure, Inc. (XCUR) Q3 Earnings Expected to Decline

Exicure, Inc. (XCUR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

4 weeks ago - Zacks Investment Research

Exicure to Present at Upcoming Scientific Conferences

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure announced presentations at TIDES EU and Neuroscience 2021 (The Society for Neuroscience).

1 month ago - Business Wire

Exicure to Present at the Chardan Virtual 5th Annual Genetic Medicines Conference

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced a presentation at the Chardan Virtual 5th Annual Genetic Medicines Conference on Tuesday, October 5, 2021.

1 month ago - Business Wire

Exicure to Participate in Upcoming Scientific Conferences

CHICAGO & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure today announced participation in TIDES USA 2021 and the 17th Annual Meeting of the Oligonucleotide Therapeutics Society.

2 months ago - Business Wire

Exicure to Participate in Upcoming Investor Conferences

CHICAGO, & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Exicure to Participate in Upcoming Investor Conferences.

3 months ago - Business Wire